Delivery Order SPE2DB24D6044-SPE2DB25FLJPM
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,024.55 to AmerisourceBergen Drug Corp on September 10, 2025, for URE-NA 15 gram powder packets (8 units). This firm fixed price delivery order, which is a child contract under a larger indefinite delivery vehicle, was competitively awarded without a set-aside designation and is scheduled for completion by September 11, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,195.41 to AmerisourceBergen Drug Corp for Polyethylene Glycol 3350 Powder 30s, a pharmaceutical product commonly used for bowel preparation and constipation relief. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award through open procurement channels. The performance location is AmerisourceBergen's Corporate Office facility in Conshohocken, Pennsylvania, with an ultimate...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order valued at $1,444.50 to AmerisourceBergen Drug Corp on July 23, 2025, with an ultimate completion date of July 24, 2025. This contract represents a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award employs firm fixed pricing with no set-aside designation,...
- The U.S. Department of Defense (DOD) Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order (Contract No. SPE2DX15D1021|SPE2DX24FHQUK) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,956,715 units of MOVIPREP Powder Packets. The delivery order has a ceiling value of $1,068.90 and a period of performance through March 14, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will deliver these...
- The Defense Logistics Agency awarded a $1,844.56 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Lactulose 10 GM packets in unit dose packaging (30 count). This competitively awarded, firm fixed price delivery order is scheduled for completion by August 13, 2025, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Mucus Relief ER 600 mg tablets (500-count units) with a ceiling value of $1,572.44 and an ultimate completion date of September 15, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, a major...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,440.70 to AmerisourceBergen Drug Corp on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,250.47 to AmerisourceBergen Drug Corp on August 16, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,165.02 to AmerisourceBergen Drug Corp for MOVIPREP powder packets, with a completion date of September 30, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. The award was made on a competitive basis with no set-aside...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,742.76 to AmerisourceBergen Drug Corp on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate...
- SPE2DB24D6044Indefinite Delivery Contract
- SPE2DB24D6044-SPE2DB25FLJPMDelivery Order
The Defense Logistics Agency awarded a $1,900.50 delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of MiraLAX Powder Packet 24s, with final delivery due by September 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's prime IDC SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle for the Defense Health Agency and broader military healthcare systems, supplying an extensive range of pharmaceutical products including specialty medications, generic and brand-name drugs, vaccines, and medical supplies across multiple therapeutic domains. The award demonstrates AmerisourceBergen's continued role as a critical pharmaceutical distributor supporting federal medical procurement needs for defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/29/25 |